MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Clinical trials for MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM trials appear
Sign up with your email to follow new studies for MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to shrink HER2-Positive tumors
Disease control Recruiting nowThis study tests whether adding palbociclib to neratinib works better than neratinib alone for people with HER2-positive solid tumors (excluding breast cancer). Both drugs block signals that help cancer cells grow. The trial enrolls 70 adults with advanced or recurrent gynecologi…
Matched conditions: MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Experimental drug plus radiation shows promise for recurrent gynecologic cancers
Disease control Recruiting nowThis early-phase trial is testing the drug talazoparib together with radiation therapy in 24 women whose gynecologic cancer (ovarian, endometrial, cervical, or related cancers) has come back after previous treatment. Talazoparib blocks enzymes that cancer cells need to grow, and …
Matched conditions: MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Could a hormone cream ease Post-Radiation vaginal pain? new trial investigates
Symptom relief Recruiting nowThis phase 2 trial tests whether a vaginal DHEA suppository can safely improve vaginal health in 25 women who had radiation for gynecologic, anal, or rectal cancer. Radiation often causes dryness, burning, and pain, similar to menopause. DHEA is a hormone replacement that may hel…
Matched conditions: MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Phase: PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Which painkiller works best after gynecologic cancer surgery? new trial aims to find out
Symptom relief Recruiting nowThis study compares two opioid pain medicines—methadone given through an IV and hydromorphone injected into the spine—for pain relief after gynecologic cancer surgery. About 140 women will take part, and researchers will measure their pain scores and side effects like itching and…
Matched conditions: MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Seaweed extract tested as chemo fatigue fighter
Symptom relief Recruiting nowThis study tests whether fucoidan, a supplement from brown seaweed, can prevent or reduce fatigue in people with gastrointestinal or gynecologic cancers who are starting chemotherapy. About 34 participants will receive either fucoidan or a placebo daily for up to 16 weeks. Resear…
Matched conditions: MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Home workouts may ease cancer Survivors' pain and fatigue
Symptom relief Recruiting nowThis pilot study tests whether an individualized online home-based exercise program can reduce pain, fatigue, sleep problems, depression, and memory issues in gynecologic cancer survivors. Forty women who have finished cancer treatment will follow a tailored exercise plan via Zoo…
Matched conditions: MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 26, 2026 16:44 UTC
-
New trial uses DNA tests to match cancer patients to targeted drug cocktails
Knowledge-focused Recruiting nowThis large screening trial enrolls up to 2,900 people with advanced solid tumors that have spread or not responded to standard treatment. Researchers use genetic tests on tumor samples to find specific mutations, then assign patients to treatment trials testing drug combinations …
Matched conditions: MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Are cancer surgeons missing a key step to prevent deadly clots?
Knowledge-focused Recruiting nowThis study surveys 500 surgeons and advanced practice providers across the U.S. to see how often they prescribe blood thinners after cancer surgery to prevent dangerous blood clots. The goal is to understand current practices and find ways to improve care. No new treatments are b…
Matched conditions: MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
New study aims to uncover cancer genes in underrepresented populations
Knowledge-focused Recruiting nowThis study is looking at how cancer genetic testing works in people from different ethnic backgrounds. Researchers will collect blood samples and genetic information from 1,800 adults with various solid tumors. The goal is to find cancer-related gene mutations and see if current …
Matched conditions: MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Can frailty predict cancer recovery? new study aims to find out
Knowledge-focused Recruiting nowThis study follows 500 adults with newly diagnosed gynecologic cancer to understand how frailty—a state of increased vulnerability—impacts their recovery and quality of life. Researchers will assess physical function, collect questionnaires, and review surgical outcomes. The goal…
Matched conditions: MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC